rs12095085

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_206933.4(USH2A):​c.11389+9A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 1,609,608 control chromosomes in the GnomAD database, including 13,110 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1273 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11837 hom. )

Consequence

USH2A
NM_206933.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.449

Publications

4 publications found
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
USH2A Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 39
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-215758586-T-A is Benign according to our data. Variant chr1-215758586-T-A is described in ClinVar as Benign. ClinVar VariationId is 48372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.11389+9A>T intron_variant Intron 58 of 71 ENST00000307340.8 NP_996816.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.11389+9A>T intron_variant Intron 58 of 71 1 NM_206933.4 ENSP00000305941.3
USH2AENST00000674083.1 linkc.11389+9A>T intron_variant Intron 58 of 72 ENSP00000501296.1

Frequencies

GnomAD3 genomes
AF:
0.123
AC:
18727
AN:
151992
Hom.:
1271
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.135
Gnomad AMI
AF:
0.148
Gnomad AMR
AF:
0.0990
Gnomad ASJ
AF:
0.135
Gnomad EAS
AF:
0.000963
Gnomad SAS
AF:
0.0452
Gnomad FIN
AF:
0.145
Gnomad MID
AF:
0.0828
Gnomad NFE
AF:
0.131
Gnomad OTH
AF:
0.144
GnomAD2 exomes
AF:
0.104
AC:
26024
AN:
250720
AF XY:
0.104
show subpopulations
Gnomad AFR exome
AF:
0.132
Gnomad AMR exome
AF:
0.0683
Gnomad ASJ exome
AF:
0.132
Gnomad EAS exome
AF:
0.000326
Gnomad FIN exome
AF:
0.150
Gnomad NFE exome
AF:
0.129
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
AF:
0.123
AC:
179171
AN:
1457498
Hom.:
11837
Cov.:
34
AF XY:
0.122
AC XY:
88177
AN XY:
725324
show subpopulations
African (AFR)
AF:
0.135
AC:
4511
AN:
33396
American (AMR)
AF:
0.0699
AC:
3126
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
3506
AN:
26110
East Asian (EAS)
AF:
0.000177
AC:
7
AN:
39644
South Asian (SAS)
AF:
0.0545
AC:
4696
AN:
86182
European-Finnish (FIN)
AF:
0.151
AC:
7958
AN:
52692
Middle Eastern (MID)
AF:
0.126
AC:
650
AN:
5152
European-Non Finnish (NFE)
AF:
0.133
AC:
147313
AN:
1109370
Other (OTH)
AF:
0.123
AC:
7404
AN:
60236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
7039
14079
21118
28158
35197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5268
10536
15804
21072
26340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.123
AC:
18731
AN:
152110
Hom.:
1273
Cov.:
32
AF XY:
0.122
AC XY:
9048
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.135
AC:
5602
AN:
41490
American (AMR)
AF:
0.0987
AC:
1508
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.135
AC:
470
AN:
3470
East Asian (EAS)
AF:
0.000966
AC:
5
AN:
5178
South Asian (SAS)
AF:
0.0450
AC:
217
AN:
4824
European-Finnish (FIN)
AF:
0.145
AC:
1539
AN:
10578
Middle Eastern (MID)
AF:
0.0822
AC:
24
AN:
292
European-Non Finnish (NFE)
AF:
0.131
AC:
8930
AN:
67978
Other (OTH)
AF:
0.142
AC:
301
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
859
1719
2578
3438
4297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.104
Hom.:
334
Bravo
AF:
0.120
Asia WGS
AF:
0.0250
AC:
88
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Feb 19, 2008
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 18, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Usher syndrome type 2A Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
7.2
DANN
Benign
0.55
PhyloP100
0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12095085; hg19: chr1-215931928; API